The Beneficial Effects of L. reuteri Probiotics in Development of the Toddlers' Immune Systems and Gut Health in Bangladesh

Sultana Begum; Archana Dev; Nurul Alam Khan; Ranjith Debnath; Mozammel Haque; Mohammad Amjad Hossain; Mohammad Sakhawat Hossain; Rakibul Hasan

doi:doi:10.11648/j.iji.20231102.12

Review Article |

The Beneficial Effects of L. reuteri Probiotics in Development of the Toddlers' Immune Systems and Gut Health in Bangladesh

Sultana Begum, Archana Dev, Nurul Alam Khan, Ranjith Debnath, Mozammel Haque, Mohammad Amjad Hossain, Mohammad Sakhawat Hossain, Rakibul Hasan

Published in International Journal of Immunology (Volume 11, Issue 2)

Received: 14 September 2023 Accepted: 4 October 2023 Published: 30 October 2023

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

A well-researched probiotic bacteria called Lactobacillus reuteri (L. reuteri) has the ability to colonize several animals. L. reuteri can be found in the skin, breast milk, urinary tract, gastrointestinal tract, and other parts of the human body. Different people have varying amounts of L. reuteri. There are a number of advantages to L. reuteri. First, L. reuteri has the ability to create compounds that are antimicrobial, such as organic acids, ethanol, and reuteri. L. reuteri's antimicrobial activity enables it to prevent the colonization of pathogenic bacteria and alter the composition of the host's commensal microbiota. Second, L. reuteri can strengthen the immune system of the host. For instance, some L. reuteri strains can enhance the formation and activity of regulatory T cells while suppressing the production of pro-inflammatory cytokines. Third, because L. reuteri has the possibility to fortify the intestinal barrier, its colonization may lessen the number of bacteria that move from the gut lumen to tissues. It has been proposed that microbial translocation across the gut epithelium causes inflammation to start. Therefore, boosting the colonization of L. reuteri may help to alleviate inflammatory illnesses, including those that affect the gut as well as distant organs. Notably, during the past few decades, L. reuteri abundance in humans has declined, and at the same time, inflammatory illness occurrences in toddlers have increased. For the correct developmental growth of toddlers, obvious supplementation, or prebiotic modification of L. reuteri may be an alluring preventative and/or therapeutic pathway counter to inflammatory illnesses.

Published in	International Journal of Immunology (Volume 11, Issue 2)
DOI	10.11648/j.iji.20231102.12
Page(s)	17-28
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Lactobacillus Reuteri, Microbiota, Probiotic, Immune System, Inflammatory Diseases, Toddler, Gut Health

References

[1]	Fijan S. Microorganisms with claimed probiotic properties: An overview of recent literature. Int J Environ Res Public Health. 2014; 11 (5): 4745-67. http://doi.org/10.3390/ijerph110504745 PMid: 24859749.
[2]	Shi LH, Balakrishnan K, Thiagarajah K, Ismail NI, Yin OS. Beneficial properties of probiotics. Trop Life Sci Res. 2016; 27 (2): 73-90. http://doi.org/10.21315/tlsr2016.27.2.6 PMid: 27688852.
[3]	Stavropoulou E, Bezirtzoglou E. Probiotics in medicine: A long debate. Front Immunol. 2020; 11: 2192. http://doi.org/10.3389/ fimmu.2020.02192 PMid: 33072084.
[4]	LeBlanc JG, Chain F, Martín R, Bermúdez-Humarán LG, Courau S, Langella P. Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microb Cell Fact. 2017; 16 (1): 79. http://doi.org/10.1186/s12934-017-0691-z PMid: 28482838.
[5]	Manor O, Dai CL, Kornilov SA, Smith B, Price ND, Lovejoy JC, et al. Health and disease markers correlate with gut microbiome composition across thousands of people. Nat Commun. 2020; 11 (1): 5206. http://doi.org/10.1038/s41467-020-18871-1 PMid: 33060586.
[6]	Qinghui Mu, Vincent J. Tavella and Xin M. Luo: Role of Lactobacillus reuteri in Human Health and Diseases: April 2018, Volume 9, Article 757.
[7]	Zihan Yu, Jihua Chen, Yaxin Liu, Qingguo Meng, Hang Liu1, Qinyan Yao, Wenxuan Song, Xiangfeng Ren and Xin Chen: The role of potential probiotic strains Lactobacillus reuteri in various intestinal diseases: New roles for an old player: 02 February 2023.
[8]	Sun Ae Kim, Min Ji Jang, Seo Young Kim, Yichao Yang, Hilary O. Pavlidis and Steven C. Ricke: Potential for Prebiotics as Feed Additives to Limit Foodborne Campylobacter Establishment in the Poultry Gastrointestinal Tract: 31 January 2019.
[9]	Sara E Jones and James Versalovic: Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors: BMC Microbiology 2009, 9: 35.
[10]	Krisztián P. Bene1, Devon W. Kavanaugh, Charlotte Leclaire, Allan P. Gunning, Donald A. MacKenzie, Alexandra Wittmann, Ian D. Young, Norihito Kawasaki, Eva Rajnavolgyi and Nathalie Juge: Lactobacillus reuteri Surface Mucus Adhesins Upregulate Inflammatory Responses Through Interactions with Innate C-Type Lectin Receptors: March 2017, Volume 8, Article 321.
[11]	Steven A Frese, Donald A Mackenzie, Daniel A Peterson, Robert Schmaltz, Teresa Fangman, You Zhou, Chaomei Zhang, Andrew K Benson, Liz A Cody, Francis Mulholland, Nathalie Juge, Jens Walter: Molecular Characterization of Host-Specific Biofilm Formation in a Vertebrate Gut Symbiont: December 2013, Volume, Issue 12.
[12]	Geoffrey A. Preidis, and James Versalovic: Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era: Gastroenterology. 2009 May; 136 (6): 2015–2031.
[13]	Yan Yang, Xin Zhao, Anh Le, Ruurd T Zijlstra, Michael G Gänzle: Reutericyclin producing Lactobacillus reuteri modulates development of fecal microbiota in weanling pigs: August 2015, Frontiers in Microbiology 6: 762.
[14]	Zunaira Iqbal, Shahzaib Ahmed, Natasha Tabassum, Riya Bhattacharya, Debajyoti Bose: Role of probiotics in prevention and treatment of enteric infections: a comprehensive review: 3 Biotech (2021) 11: 242.
[15]	Hiroyuki Tezuka and Toshiaki Ohteki: Regulation of IgA Production by Intestinal Dendritic Cells and Related Cells: Regulation of IgA Production by Intestinal Dendritic Cells and Related Cells: published: 13 August 2019.
[16]	Musjaya Guli1, Sri Winarsih, Wisnu Barlianto, Oski Illiandri, S. P. Sumarno: Mechanism of Lactobacillus reuteri Probiotic in Increasing Intestinal Mucosal Immune System:. 2021 Nov 23; 9 (F): 784-793.
[17]	Chiara Mazziotta, Mauro Tognon, Fernanda Martini, Elena Torreggiani and John Charles Rotondo: Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health: Cells 2023, 12, 184.
[18]	Collins FL, Irwin R, Bierhalter H, Schepper J, Britton RA, Parameswaran N, McCabe LR.: Lactobacillus reuteri 6475 Increases Bone Density in Intact Females Only under an Inflammatory Setting. PLoS One. 2016 Apr 8; 11 (4): e0153180.
[19]	Hunter C, Dimaguila MA, Gal P, Wimmer JE Jr, Ransom JL, Carlos RQ, Smith M, Davanzo CC. Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight < 1000 grams: a sequential analysis. BMC Pediatr. 2012 Sep 4; 12: 142.
[20]	Jingbo Zhou, Gaoshun Xu, Xinyue Li, Huayu Tu, Haoyu Li, Hong Chang, Jie Chen, Renqiang Yu, Ce Qi and Jin Sun: Limosilactobacillus reuteri FN041 prevents atopic dermatitis in pup mice by remodeling the ileal microbiota and regulating gene expression in Peyer’s patches after vertical transmission: Front Nutr. 2022 Sep 28; 9: 987400.
[21]	Rumman N, Sultan M, El-Chammas K, Goh V, Salzman N, Quintero D, Werlin S. Calprotectin in cystic fibrosis. BMC Pediatr. 2014 May 29; 14: 133.
[22]	https://www.bcm.edu/research/faculty-labs/james-versalovic-lab/research/completed-projects/l-reuteri-mediated-immunomodulation
[23]	Chunxu Gao, Angela Major, David Rendon, Monica Lugo, Vanessa Jackson, Zhongcheng Shi, Yuko Mori-Akiyama, James Versalovic: Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri: https://doi.org/10.1128/mbio.01358-15
[24]	Giovanni Schepici1, Serena Silvestro1, Placido Bramanti1, and Emanuele Mazzon: The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials: 2019, Vol. 28(12) 1507–1527.
[25]	Tom Maier: Oral Microbiome in Health and Disease: Maintaining a Healthy, Balanced Ecosystem and Reversing Dysbiosis: Microorganisms 2023, 11, 1453.
[26]	Jens Walter, Robert A Britton, Stefan Roos: Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm: 10.1073/pnas.1000099107.
[27]	Zichen Luo, Ailing Chen, Anni Xie, Xueying Liu, Shanyu Jiang, Renqiang Yu: Limosilactobacillus reuteri in immunomodulation: molecular mechanisms and potential applications: DOI 10.3389/fimmu.2023.1228754.
[28]	Steven A Frese, Andrew K Benson, Gerald W Tannock, Diane M Loach, Jaehyoung Kim, Min Zhang, Phaik Lyn Oh, Nicholas C K Heng, Prabhu B Patil, Nathalie Juge, Donald A Mackenzie, Bruce M Pearson, Alla Lapidus, Eileen Dalin, Hope Tice, Eugene Goltsman, Miriam Land, Loren Hauser, Natalia Ivanova, Nikos C Kyrpides, Jens Walter: The evolution of host specialization in the vertebrate gut symbiont Lactobacillus reuteri: 2011 Feb; 7(2): e1001314.
[29]	T L Talarico, W J Dobrogosz: Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri: Antimicrob Agents Chemother 1989 May; 33(5): 674-9.
[30]	Stevens, C., Stringfellow, J., Wakelin, K. and Waring, J. (2011) The UK Gestalt Psychotherapy CORE Research Project: The Findings. British Gestalt Journal, 20, 22-27.
[31]	Jan F Stevens, Claudia S Maier: Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease: Mol Nutr Food Res 2008 Jan; 52(1): 7-25.
[32]	Mohamed H. Emara, Salem Y. Mohamed, and Hesham R. Abdel-Aziz: Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial: Therap Adv Gastroenterol. 2014 Jan; 7(1): 4–13.
[33]	Engevik MA, Morra CN, Röth D, Engevik K, Spinler JK, Devaraj S, Crawford SE, Estes MK, Kalkum M, Versalovic J. Microbial Metabolic Capacity for Intestinal Folate Production and Modulation of Host Folate Receptors. Front Microbiol. 2019 Oct 9; 10: 2305. doi: 10.3389/fmicb.2019.02305. PMID: 31649646; PMCID: PMC6795088.
[34]	Gao H, Korn JM, Ferretti S, Monahan JE, Wang Y, Singh M, Zhang C, Schnell C, Yang G, Zhang Y, Balbin OA, Barbe S, Cai H, Casey F, Chatterjee S, Chiang DY, Chuai S, Cogan SM, Collins SD, Dammassa E, Ebel N, Embry M, Green J, Kauffmann A, Kowal C, Leary RJ, Lehar J, Liang Y, Loo A, Lorenzana E, Robert McDonald E 3rd, McLaughlin ME, Merkin J, Meyer R, Naylor TL, Patawaran M, Reddy A, Röelli C, Ruddy DA, Salangsang F, Santacroce F, Singh AP, Tang Y, Tinetto W, Tobler S, Velazquez R, Venkatesan K, Von Arx F, Wang HQ, Wang Z, Wiesmann M, Wyss D, Xu F, Bitter H, Atadja P, Lees E, Hofmann F, Li E, Keen N, Cozens R, Jensen MR, Pryer NK, Williams JA, Sellers WR. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. Nat Med. 2015 Nov; 21(11): 1318-25. doi: 10.1038/nm.3954. Epub 2015 Oct 19. PMID: 26479923.
[35]	D. Travis Thomas, Louise M Burke, Kelly Anne Erdman: Nutrition and Athletic Performance: March 2016 Medicine and Science in Sports and Exercise 48(3): 543-568.
[36]	Linares DM, Gómez C, Renes E, Fresno JM, Tornadijo ME, Ross RP, Stanton C. Lactic Acid Bacteria and Bifidobacteria with Potential to Design Natural Biofunctional Health-Promoting Dairy Foods. Front Microbiol. 2017 May 18; 8: 846. doi: 10.3389/fmicb.2017.00846. PMID: 28572792; PMCID: PMC5435742.
[37]	Molina-Azorín, J. F., et al. (2009) Quality Management, Environmental Management and Firm Performance: A Review of Empirical Studies and Issues of Integration. International Journal of Management Reviews, 11, 197-222. http://dx.doi.org/10.1111/j.1468-2370.2008.00238.
[38]	Romani Vestman N, Chen T, Lif Holgerson P, Öhman C, Johansson I. Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial. PLoS One. 2015 May 6; 10(5): e0125812. doi: 10.1371/journal.pone.0125812. PMID: 25946126; PMCID: PMC4422650.

Cite This Article

Plain Text BibTeX RIS

APA Style

Sultana Begum, Archana Dev, Nurul Alam Khan, Ranjith Debnath, Mozammel Haque, et al. (2023). The Beneficial Effects of L. reuteri Probiotics in Development of the Toddlers' Immune Systems and Gut Health in Bangladesh. International Journal of Immunology, 11(2), 17-28. https://doi.org/10.11648/j.iji.20231102.12

Copy | Download

ACS Style

Sultana Begum; Archana Dev; Nurul Alam Khan; Ranjith Debnath; Mozammel Haque, et al. The Beneficial Effects of L. reuteri Probiotics in Development of the Toddlers' Immune Systems and Gut Health in Bangladesh. Int. J. Immunol. 2023, 11(2), 17-28. doi: 10.11648/j.iji.20231102.12

Copy | Download

AMA Style

Sultana Begum, Archana Dev, Nurul Alam Khan, Ranjith Debnath, Mozammel Haque, et al. The Beneficial Effects of L. reuteri Probiotics in Development of the Toddlers' Immune Systems and Gut Health in Bangladesh. Int J Immunol. 2023;11(2):17-28. doi: 10.11648/j.iji.20231102.12

Copy | Download

@article{10.11648/j.iji.20231102.12,
  author = {Sultana Begum and Archana Dev and Nurul Alam Khan and Ranjith Debnath and Mozammel Haque and Mohammad Amjad Hossain and Mohammad Sakhawat Hossain and Rakibul Hasan},
  title = {The Beneficial Effects of L. reuteri Probiotics in Development of the Toddlers' Immune Systems and Gut Health in Bangladesh},
  journal = {International Journal of Immunology},
  volume = {11},
  number = {2},
  pages = {17-28},
  doi = {10.11648/j.iji.20231102.12},
  url = {https://doi.org/10.11648/j.iji.20231102.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.iji.20231102.12},
  abstract = {A well-researched probiotic bacteria called Lactobacillus reuteri (L. reuteri) has the ability to colonize several animals. L. reuteri can be found in the skin, breast milk, urinary tract, gastrointestinal tract, and other parts of the human body. Different people have varying amounts of L. reuteri. There are a number of advantages to L. reuteri. First, L. reuteri has the ability to create compounds that are antimicrobial, such as organic acids, ethanol, and reuteri. L. reuteri's antimicrobial activity enables it to prevent the colonization of pathogenic bacteria and alter the composition of the host's commensal microbiota. Second, L. reuteri can strengthen the immune system of the host. For instance, some L. reuteri strains can enhance the formation and activity of regulatory T cells while suppressing the production of pro-inflammatory cytokines. Third, because L. reuteri has the possibility to fortify the intestinal barrier, its colonization may lessen the number of bacteria that move from the gut lumen to tissues. It has been proposed that microbial translocation across the gut epithelium causes inflammation to start. Therefore, boosting the colonization of L. reuteri may help to alleviate inflammatory illnesses, including those that affect the gut as well as distant organs. Notably, during the past few decades, L. reuteri abundance in humans has declined, and at the same time, inflammatory illness occurrences in toddlers have increased. For the correct developmental growth of toddlers, obvious supplementation, or prebiotic modification of L. reuteri may be an alluring preventative and/or therapeutic pathway counter to inflammatory illnesses.
},
 year = {2023}
}

Copy | Download

TY - JOUR
T1 - The Beneficial Effects of L. reuteri Probiotics in Development of the Toddlers' Immune Systems and Gut Health in Bangladesh
AU - Sultana Begum
AU - Archana Dev
AU - Nurul Alam Khan
AU - Ranjith Debnath
AU - Mozammel Haque
AU - Mohammad Amjad Hossain
AU - Mohammad Sakhawat Hossain
AU - Rakibul Hasan
Y1 - 2023/10/30
PY - 2023
N1 - https://doi.org/10.11648/j.iji.20231102.12
DO - 10.11648/j.iji.20231102.12
T2 - International Journal of Immunology
JF - International Journal of Immunology
JO - International Journal of Immunology
SP - 17
EP - 28
PB - Science Publishing Group
SN - 2329-1753
UR - https://doi.org/10.11648/j.iji.20231102.12
AB - A well-researched probiotic bacteria called Lactobacillus reuteri (L. reuteri) has the ability to colonize several animals. L. reuteri can be found in the skin, breast milk, urinary tract, gastrointestinal tract, and other parts of the human body. Different people have varying amounts of L. reuteri. There are a number of advantages to L. reuteri. First, L. reuteri has the ability to create compounds that are antimicrobial, such as organic acids, ethanol, and reuteri. L. reuteri's antimicrobial activity enables it to prevent the colonization of pathogenic bacteria and alter the composition of the host's commensal microbiota. Second, L. reuteri can strengthen the immune system of the host. For instance, some L. reuteri strains can enhance the formation and activity of regulatory T cells while suppressing the production of pro-inflammatory cytokines. Third, because L. reuteri has the possibility to fortify the intestinal barrier, its colonization may lessen the number of bacteria that move from the gut lumen to tissues. It has been proposed that microbial translocation across the gut epithelium causes inflammation to start. Therefore, boosting the colonization of L. reuteri may help to alleviate inflammatory illnesses, including those that affect the gut as well as distant organs. Notably, during the past few decades, L. reuteri abundance in humans has declined, and at the same time, inflammatory illness occurrences in toddlers have increased. For the correct developmental growth of toddlers, obvious supplementation, or prebiotic modification of L. reuteri may be an alluring preventative and/or therapeutic pathway counter to inflammatory illnesses.

VL - 11
IS - 2
ER -

Copy | Download

Author Information

Sultana Begum

Department of Paediatric, North East Medical College Hospital, Sylhet, Bangladesh
Archana Dev

Department of Paediatric, Jalalabad Ragib Rabeya Medical College Hospital, Sylhet, Bangladesh
Nurul Alam Khan

Department of Paediatric, Red Crescent Matrimongol Hospital, Sylhet, Bangladesh
Ranjith Debnath

Department of Paediatric, Lion Children Hospital, Sylhet, Bangladesh
Mozammel Haque

Department of Paediatrics, 250 Bedded Moulvibazar Sadar Hospital, Sylhet, Bangladesh
Mohammad Amjad Hossain

Department of Paediatrics, The Labaid Specialized Hospital, Brahmanbaria, Bangladesh
Mohammad Sakhawat Hossain

Department of Paediatrics, 250 Bedded General Hospital, Kishoreganj, Bangladesh
Rakibul Hasan

Department of Paediatrics, Christian Medical Center, Brahmanbaria, Bangladesh

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Sultana Begum, Archana Dev, Nurul Alam Khan, Ranjith Debnath, Mozammel Haque, et al. (2023). The Beneficial Effects of L. reuteri Probiotics in Development of the Toddlers' Immune Systems and Gut Health in Bangladesh. International Journal of Immunology, 11(2), 17-28. https://doi.org/10.11648/j.iji.20231102.12

Copy | Download

ACS Style

Sultana Begum; Archana Dev; Nurul Alam Khan; Ranjith Debnath; Mozammel Haque, et al. The Beneficial Effects of L. reuteri Probiotics in Development of the Toddlers' Immune Systems and Gut Health in Bangladesh. Int. J. Immunol. 2023, 11(2), 17-28. doi: 10.11648/j.iji.20231102.12

Copy | Download

AMA Style

Sultana Begum, Archana Dev, Nurul Alam Khan, Ranjith Debnath, Mozammel Haque, et al. The Beneficial Effects of L. reuteri Probiotics in Development of the Toddlers' Immune Systems and Gut Health in Bangladesh. Int J Immunol. 2023;11(2):17-28. doi: 10.11648/j.iji.20231102.12

Copy | Download

@article{10.11648/j.iji.20231102.12,
  author = {Sultana Begum and Archana Dev and Nurul Alam Khan and Ranjith Debnath and Mozammel Haque and Mohammad Amjad Hossain and Mohammad Sakhawat Hossain and Rakibul Hasan},
  title = {The Beneficial Effects of L. reuteri Probiotics in Development of the Toddlers' Immune Systems and Gut Health in Bangladesh},
  journal = {International Journal of Immunology},
  volume = {11},
  number = {2},
  pages = {17-28},
  doi = {10.11648/j.iji.20231102.12},
  url = {https://doi.org/10.11648/j.iji.20231102.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.iji.20231102.12},
  abstract = {A well-researched probiotic bacteria called Lactobacillus reuteri (L. reuteri) has the ability to colonize several animals. L. reuteri can be found in the skin, breast milk, urinary tract, gastrointestinal tract, and other parts of the human body. Different people have varying amounts of L. reuteri. There are a number of advantages to L. reuteri. First, L. reuteri has the ability to create compounds that are antimicrobial, such as organic acids, ethanol, and reuteri. L. reuteri's antimicrobial activity enables it to prevent the colonization of pathogenic bacteria and alter the composition of the host's commensal microbiota. Second, L. reuteri can strengthen the immune system of the host. For instance, some L. reuteri strains can enhance the formation and activity of regulatory T cells while suppressing the production of pro-inflammatory cytokines. Third, because L. reuteri has the possibility to fortify the intestinal barrier, its colonization may lessen the number of bacteria that move from the gut lumen to tissues. It has been proposed that microbial translocation across the gut epithelium causes inflammation to start. Therefore, boosting the colonization of L. reuteri may help to alleviate inflammatory illnesses, including those that affect the gut as well as distant organs. Notably, during the past few decades, L. reuteri abundance in humans has declined, and at the same time, inflammatory illness occurrences in toddlers have increased. For the correct developmental growth of toddlers, obvious supplementation, or prebiotic modification of L. reuteri may be an alluring preventative and/or therapeutic pathway counter to inflammatory illnesses.
},
 year = {2023}
}

Copy | Download

VL - 11
IS - 2
ER -

Copy | Download